indazoles has been researched along with Psoriasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Liu, J; Tian, C; Xia, A; Xia, Z; Yang, S; You, J; Zhang, G | 1 |
| Carnerup, MA; Dack, KN; Eirefelt, S; Henriksson, K; Johnson, PS; Ollerstam, AK; Stahlhut, M | 1 |
| Chuang, TH; Hsu, LC; Lai, CY; Lin, KI; Su, YW | 1 |
| Dainichi, T; Hirakawa, S; Honda, T; Kabashima, K; Kitoh, A; Miyachi, Y; Nakajima, S; Nakashima, C; Nonomura, Y; Otsuka, A; Wong, LS; Yamamoto, Y | 1 |
| Callens, E; Djebbar, R; Ruff, F; Santais, MC | 1 |
| Ormea, F | 1 |
2 review(s) available for indazoles and Psoriasis
| Article | Year |
|---|---|
Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cytokines; Dermatitis; Endosomes; Humans; Imiquimod; Indazoles; Isonicotinic Acids; Mice; Psoriasis; Resveratrol; Signal Transduction; Skin; Stilbenes; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Toll-Like Receptors | 2017 |
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Asthma; Bronchoconstriction; Child; Clinical Trials as Topic; Crohn Disease; Cystic Fibrosis; Haplorhini; Humans; Hydroxyurea; Indazoles; Indoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phenylcarbamates; Psoriasis; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Sulfonamides; Tetrazoles; Tosyl Compounds | 1998 |
4 other study(ies) available for indazoles and Psoriasis
| Article | Year |
|---|---|
Discovery of 5-((1H-indazol-3-yl) methylene)-2-thioxoimidazolidin-4-one derivatives as a new class of AHR agonists with anti-psoriasis activity in a mouse model.
Topics: Animals; Imiquimod; Indazoles; Mice; Psoriasis; Receptors, Aryl Hydrocarbon; Skin | 2023 |
Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.
Topics: Administration, Topical; Dermatitis, Atopic; Drug Design; Drug Stability; Half-Life; Humans; Indazoles; Leukocytes, Mononuclear; Lipopolysaccharides; Psoriasis; Receptors, Glucocorticoid; Steroids; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2020 |
Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice.
Topics: Aminoquinolines; Animals; Axitinib; Dermatitis, Atopic; Disease Models, Animal; Epidermis; Humans; Imidazoles; Imiquimod; Indazoles; Mice; Pruritus; Psoriasis; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2016 |
[The external treatment of dermatoses (author's transl)].
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Dermatologic Agents; Drug Interactions; Glucocorticoids; Humans; Indazoles; Ointments; Pharmaceutical Vehicles; Precancerous Conditions; Psoriasis; Skin; Skin Absorption; Skin Diseases; Skin Neoplasms | 1974 |